Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Siwei Yiqi is a traditional Chinese medicine (TCM) product developed and manufactured by Tianjin Hong Ren Tang Pharmaceutical. Formulated as an oral capsule, it is primarily indicated as a tonic to replenish 'Qi' (vital energy) in patients experiencing Qi deficiency or low energy states. The preparation is a Chinese Patent Medicine (Zhongchengyao) that utilizes a combination of four traditional herbal ingredients to restore physiological balance and vitality. It is currently approved and marketed in China for these traditional indications. As is common with traditional herbal formulations, its therapeutic effects are attributed to the synergistic action of multiple phytochemical constituents rather than a single defined molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Siwei Yiqi.